Document Detail


Histone deacetylase inhibitor, MGCD0103, synergizes with gemcitabine in human pancreatic cells.
MedLine Citation:
PMID:  21375679     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Histone deacetylase inhibitors are a group of recently developed compounds that modulate cell growth and survival. We evaluated effects of the HDAC inhibitor, MGCD0103, on growth of pancreatic carcinoma models following single agent treatment and in combination with gemcitabine. MGCD0103 inhibited tumor cell growth and acted synergistically with gemcitabine to enhance its cytotoxic effects. Gene expression analysis identified the cell cycle pathway as one of the most highly modulated gene groups. Our data suggest that MGCD0103 + gemcitabine may be an effective treatment for gemcitabine-refractory pancreatic cancer.
Authors:
Victoria Sung; Normand Richard; Helen Brady; Armin Maier; Gerhard Kelter; Carla Heise
Related Documents :
15276169 - Rapid identification of stress-related fingerprint from whole bacterial cells of bifido...
19127649 - Calorimetric evaluations of bacillus subtilis vegetative and spore cells colonial growt...
2225079 - T lymphocyte stress response. ii. protection of translation and dna replication against...
21544479 - Cell proliferation and apoptosis in the exocrine pancreas of azaserine-treated rats and...
8869289 - Immunocytochemical expression of the 70 kd heat shock protein in ischaemic bowel disease.
16196909 - Tiling a plane in a dynamical process and its applications to arrays of quantum dots, d...
16820319 - Interactions of human retroviruses with the host cell cytoskeleton.
8541229 - Estrogen receptor blockade by the pure antiestrogen, zm 182780, induces death of pituit...
22785369 - French and european regulations for tissue and cell therapy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-5
Journal Detail:
Title:  Cancer science     Volume:  -     ISSN:  1349-7006     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101168776     Medline TA:  Cancer Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 Japanese Cancer Association.
Affiliation:
Celgene Corporation, 1500 Owens St. Suite 600 San Francisco, CA 94158 Celgene Corporation, 4550 Towne Centre Court San Diego, CA 92121 Oncotest GmbH, Am Flughafen 12-14 79108 Freiburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  3D/4D sonographic evaluation of amniotic band syndrome in early pregnancy: A supplement to 2D ultras...
Next Document:  Halenaquinone, a chemical compound that specifically inhibits the secondary DNA binding of RAD51.